State Street’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $486M | Buy |
8,847,751
+384,661
| +5% | +$21.1M | 0.02% | 553 |
|
2025
Q1 | $598M | Sell |
8,463,090
-649,185
| -7% | -$45.9M | 0.02% | 495 |
|
2024
Q4 | $599M | Buy |
9,112,275
+289,161
| +3% | +$19M | 0.02% | 501 |
|
2024
Q3 | $620M | Sell |
8,823,114
-812,906
| -8% | -$57.1M | 0.03% | 497 |
|
2024
Q2 | $793M | Buy |
9,636,020
+2,740,805
| +40% | +$226M | 0.03% | 402 |
|
2024
Q1 | $602M | Buy |
6,895,215
+164,700
| +2% | +$14.4M | 0.03% | 488 |
|
2023
Q4 | $649M | Buy |
6,730,515
+271,786
| +4% | +$26.2M | 0.03% | 462 |
|
2023
Q3 | $571M | Buy |
6,458,729
+505,045
| +8% | +$44.7M | 0.03% | 449 |
|
2023
Q2 | $516M | Sell |
5,953,684
-112,634
| -2% | -$9.76M | 0.03% | 500 |
|
2023
Q1 | $590M | Buy |
6,066,318
+677,474
| +13% | +$65.9M | 0.03% | 452 |
|
2022
Q4 | $558M | Buy |
5,388,844
+110,406
| +2% | +$11.4M | 0.03% | 452 |
|
2022
Q3 | $447M | Sell |
5,278,438
-117,928
| -2% | -$10M | 0.03% | 492 |
|
2022
Q2 | $447M | Buy |
5,396,366
+15,973
| +0.3% | +$1.32M | 0.03% | 506 |
|
2022
Q1 | $415M | Buy |
5,380,393
+64,300
| +1% | +$4.96M | 0.02% | 587 |
|
2021
Q4 | $470M | Buy |
5,316,093
+278,628
| +6% | +$24.6M | 0.02% | 551 |
|
2021
Q3 | $389M | Buy |
5,037,465
+130,408
| +3% | +$10.1M | 0.02% | 586 |
|
2021
Q2 | $409M | Buy |
4,907,057
+232,655
| +5% | +$19.4M | 0.02% | 592 |
|
2021
Q1 | $353M | Sell |
4,674,402
-285,377
| -6% | -$21.5M | 0.02% | 603 |
|
2020
Q4 | $435M | Buy |
4,959,779
+67,978
| +1% | +$5.96M | 0.03% | 518 |
|
2020
Q3 | $372M | Sell |
4,891,801
-254,700
| -5% | -$19.4M | 0.03% | 502 |
|
2020
Q2 | $635M | Sell |
5,146,501
-393,044
| -7% | -$48.5M | 0.05% | 364 |
|
2020
Q1 | $468M | Buy |
5,539,545
+628,230
| +13% | +$53.1M | 0.04% | 382 |
|
2019
Q4 | $415M | Buy |
4,911,315
+35,533
| +0.7% | +$3M | 0.03% | 510 |
|
2019
Q3 | $329M | Buy |
4,875,782
+186,442
| +4% | +$12.6M | 0.02% | 546 |
|
2019
Q2 | $402M | Buy |
4,689,340
+53,188
| +1% | +$4.56M | 0.03% | 500 |
|
2019
Q1 | $412M | Buy |
4,636,152
+738,589
| +19% | +$65.6M | 0.03% | 478 |
|
2018
Q4 | $332M | Sell |
3,897,563
-38,806
| -1% | -$3.3M | 0.03% | 486 |
|
2018
Q3 | $382M | Buy |
3,936,369
+133,232
| +4% | +$12.9M | 0.03% | 501 |
|
2018
Q2 | $358M | Sell |
3,803,137
-220,199
| -5% | -$20.7M | 0.03% | 510 |
|
2018
Q1 | $326M | Buy |
4,023,336
+28,761
| +0.7% | +$2.33M | 0.03% | 524 |
|
2017
Q4 | $356M | Sell |
3,994,575
-19,693
| -0.5% | -$1.76M | 0.03% | 515 |
|
2017
Q3 | $374M | Buy |
4,014,268
+118,018
| +3% | +$11M | 0.03% | 478 |
|
2017
Q2 | $354M | Sell |
3,896,250
-105,279
| -3% | -$9.56M | 0.03% | 490 |
|
2017
Q1 | $351M | Buy |
4,001,529
+258,417
| +7% | +$22.7M | 0.03% | 492 |
|
2016
Q4 | $310M | Buy |
3,743,112
+108,065
| +3% | +$8.95M | 0.03% | 509 |
|
2016
Q3 | $336M | Buy |
3,635,047
+286,010
| +9% | +$26.5M | 0.03% | 484 |
|
2016
Q2 | $261M | Buy |
3,349,037
+62,294
| +2% | +$4.85M | 0.03% | 531 |
|
2016
Q1 | $271M | Buy |
3,286,743
+175,733
| +6% | +$14.5M | 0.03% | 522 |
|
2015
Q4 | $326M | Buy |
3,111,010
+4,083
| +0.1% | +$428K | 0.04% | 461 |
|
2015
Q3 | $327M | Buy |
3,106,927
+272,434
| +10% | +$28.7M | 0.04% | 437 |
|
2015
Q2 | $388M | Buy |
2,834,493
+20,329
| +0.7% | +$2.78M | 0.04% | 416 |
|
2015
Q1 | $351M | Buy |
2,814,164
+158,546
| +6% | +$19.8M | 0.04% | 456 |
|
2014
Q4 | $240M | Sell |
2,655,618
-1,302,679
| -33% | -$118M | 0.02% | 555 |
|
2014
Q3 | $286M | Sell |
3,958,297
-359,784
| -8% | -$26M | 0.03% | 492 |
|
2014
Q2 | $269M | Buy |
4,318,081
+426,323
| +11% | +$26.5M | 0.03% | 512 |
|
2014
Q1 | $265M | Buy |
3,891,758
+706,677
| +22% | +$48.2M | 0.03% | 500 |
|
2013
Q4 | $224M | Buy |
3,185,081
+736,150
| +30% | +$51.7M | 0.02% | 552 |
|
2013
Q3 | $177M | Sell |
2,448,931
-666,175
| -21% | -$48.1M | 0.02% | 591 |
|
2013
Q2 | $174M | Buy |
+3,115,106
| New | +$174M | 0.02% | 576 |
|